Earnings Feed
Start Free
Home/Filings/4/0001437749-22-013127
4//SEC Filing

Laing Lance G. 4

Accession 0001437749-22-013127

CIK 0001603454other
View on SEC.govCompany Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 8:37 PM ET

Size

46.2 KB

Accession

0001437749-22-013127

Insider Transaction Report

Form 4
Period: 2022-05-17
Celcuity Inc.CELC
Laing Lance G.
DirectorChief Science Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−1,834→ 0 total
    Exercise: $25.77Exp: 2028-10-17→ Common Stock (1,834 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+1,834→ 1,834 total
    Exercise: $5.50Exp: 2019-10-17→ Common Stock (1,834 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−50,000→ 0 total
    Exercise: $19.72Exp: 2029-08-12→ Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+50,000→ 50,000 total
    Exercise: $5.50Exp: 2029-08-12→ Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+2,771→ 2,771 total
    Exercise: $5.50Exp: 2030-12-28→ Common Stock (2,771 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+3,215→ 3,215 total
    Exercise: $5.50Exp: 2031-02-02→ Common Stock (3,215 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−2,973→ 0 total
    Exercise: $15.92Exp: 2031-03-18→ Common Stock (2,973 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−6,754→ 0 total
    Exercise: $27.94Exp: 2031-04-12→ Common Stock (6,754 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−20,000→ 0 total
    Exercise: $20.04Exp: 2031-08-11→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−1,877→ 0 total
    Exercise: $17.19Exp: 2031-10-27→ Common Stock (1,877 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+1,877→ 1,877 total
    Exercise: $5.50Exp: 2031-10-27→ Common Stock (1,877 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−4,110→ 0 total
    Exercise: $9.50Exp: 2027-09-19→ Common Stock (4,110 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+4,110→ 4,110 total
    Exercise: $5.50Exp: 2027-09-19→ Common Stock (4,110 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−2,771→ 0 total
    Exercise: $10.35Exp: 2030-12-28→ Common Stock (2,771 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-05-17−3,215→ 0 total
    Exercise: $14.84Exp: 2031-02-02→ Common Stock (3,215 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+2,973→ 2,973 total
    Exercise: $5.50Exp: 2031-03-18→ Common Stock (2,973 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+6,754→ 6,754 total
    Exercise: $5.50Exp: 2031-04-12→ Common Stock (6,754 underlying)
  • Award

    Stock Option (right to buy)

    2022-05-17+20,000→ 20,000 total
    Exercise: $5.50Exp: 2031-08-11→ Common Stock (20,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-05-17+38,412→ 38,412 total
    Exercise: $5.50Exp: 2032-05-17→ Common Stock (38,412 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $8.40Exp: 2027-05-17→ Common Stock (16,125 underlying)
    16,125

  • Stock Option (right to buy)

    Exercise: $5.90Exp: 2030-08-12→ Common Stock (20,000 underlying)
    20,000

  • Common Stock

    1,250,000
Footnotes (12)
  • [F1]Fully vested.
  • [F10]5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter.
  • [F11]469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter.
  • [F12]These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022.
  • [F2]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.
  • [F3]458 shares vest on 10/17/19; the remaining 1,376 shares vest 1/36th per month thereafter.
  • [F4]12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter.
  • [F5]5,000 shares vest on 8/12/21; the remaining 15,000 shares vest 1/36th per month thereafter.
  • [F6]692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter.
  • [F7]803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter.
  • [F8]743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter.
  • [F9]1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter.

Documents

1 file

Issuer

Celcuity Inc.

CIK 0001603454

→
Entity typeother

Related Parties

1
  • filerCIK 0001716041

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:37 PM ET
Size
46.2 KB
View on SEC.gov